Abstract
The present disclosure relates to methods, kits, and systems for assessing the risk of a human subject for developing a cancer, including genetic risk assessment, clinical risk assessment, and combinations of both to improve risk analysis.
Full Text
What is claimed is:
The present disclosure relates to methods, kits, and systems for assessing the risk of a human subject for developing a cancer, including genetic risk assessment, clinical risk assessment, and combinations of both to improve risk analysis.
Timeline
Filed
03/13/2026Published
07/16/2026Granted
Not AvailableIPC Codes(3)
C12Q 1/6886:for cancer (immunoassay for cancer G01N 33/575)
C12Q 1/6827:for detection of mutation or polymorphism
C12Q 1/6883:for diseases caused by alterations of genetic material